Cargando…

Recurrent Cholera Outbreaks, Democratic Republic of the Congo, 2008–2017

In 2017, the exacerbation of an ongoing countrywide cholera outbreak in the Democratic Republic of the Congo resulted in >53,000 reported cases and 1,145 deaths. To guide control measures, we analyzed the characteristics of cholera epidemiology in DRC on the basis of surveillance and cholera trea...

Descripción completa

Detalles Bibliográficos
Autores principales: Ingelbeen, Brecht, Hendrickx, David, Miwanda, Berthe, van der Sande, Marianne A.B., Mossoko, Mathias, Vochten, Hilde, Riems, Bram, Nyakio, Jean-Paul, Vanlerberghe, Veerle, Lunguya, Octavie, Jacobs, Jan, Boelaert, Marleen, Kebela, Benoît Ilunga, Bompangue, Didier, Muyembe, Jean-Jacques
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6478228/
https://www.ncbi.nlm.nih.gov/pubmed/31002075
http://dx.doi.org/10.3201/eid2505.181141
Descripción
Sumario:In 2017, the exacerbation of an ongoing countrywide cholera outbreak in the Democratic Republic of the Congo resulted in >53,000 reported cases and 1,145 deaths. To guide control measures, we analyzed the characteristics of cholera epidemiology in DRC on the basis of surveillance and cholera treatment center data for 2008–2017. The 2017 nationwide outbreak resulted from 3 distinct mechanisms: considerable increases in the number of cases in cholera-endemic areas, so-called hot spots, around the Great Lakes in eastern DRC; recurrent outbreaks progressing downstream along the Congo River; and spread along Congo River branches to areas that had been cholera-free for more than a decade. Case-fatality rates were higher in nonendemic areas and in the early phases of the outbreaks, possibly reflecting low levels of immunity and less appropriate prevention and treatment. Targeted use of oral cholera vaccine, soon after initial cases are diagnosed, could contribute to lower case-fatality rates.